Randox – Drugs of Abuse

Home - General - Randox – Drugs of Abuse

Throughout November our aim is to highlight how the Randox product range can be utilised to allow for the most accurate analysis of drugs of abuse, with a particular focus placed with the Evidence MultiSTAT, a fast, fully automated and versatile immunoanalyser that enables on-site detection of up to 21 drugs of abuse from a single sample of oral fluid, urine or blood.

The abuse of drugs is a growing problem worldwide and represents a significant burden to healthcare systems as well as creating problems in an individual’s lifestyle.  It has been estimated by the WHO (World Health Organisation) that 31 million people globally suffer from drug use disorders and 3.3 million deaths each year are linked to the abuse of both drugs and alcohol.

Randox have reacted to this growing concern and are now a world leader in the drugs of abuse testing field.  Our product range currently comprises classical, prescription and synthetic drugs.

The Evidence MultiSTAT offers a simple drug screening solution to those who have little or no knowledge of laboratory procedures. As an extremely versatile, desktop analyser it is ideally suited to a variety of settings including both the clinical laboratory and the emergency room.

Evidence MultiSTAT

The Evidence MultiSTAT utilises Randox’s revolutionary Biochip Array Technology to enable on-site simultaneous detection of up to 21 classical, prescription and synthetic drugs from a single patient sample. The MultiSTAT has the ability to run samples of whole blood, urine and oral fluid with a 2 step process from sample entry to results with the first result coming through after 17 minutes. The MultiSTAT offers an extensive test menu and requires no laboratory experience with it’s simple process of providing rapid screening and reliable results.

Evidence MultiSTAT

RX series Toxicology Testing

Renowned for quality and reliability the RX series range of clinical chemistry analysers boasts a world leading test menu comprising both therapeutic drugs and drugs of abuse.  Our toxicology range comprises amphetamines, barbiturates, benzodiazepines, cannabinoids, cocaine metabolite, ecstasy, EDDP, ethanol, methadone and opiates. The RX series range of clinical chemistry analysers ensures a high degree of accuracy with a wide range of testing throughputs to suit all laboratories big or small.

RX Series

Reagents Drugs of Abuse Assays

In order to assist in dealing with the ongoing burden of substance abuse, Randox Reagents offer a comprehensive range of 10 assays to test for some of the top commonly abused substances including, alcohol, methamphetamine’s, cocaine, methadone, cannabis, benzodiazepines, barbiturates, EDDP, ecstasy and opiates.  The Randox drugs of abuse reagents are liquid ready-to-use for increased efficiency with applications available for over 30 different analysers.

Randox Reagents

RIQAS Urine Toxicology Programme

Designed to monitor the performance of 20 drugs of abuse tests in urine, our RIQAS urine toxicology EQA program is suitable for both qualitative and quantitative methods of analysis.  As the largest EQA scheme in the world, access to large peer groups is guaranteed.  Additional benefits include; monthly analysis, user-friendly reports allowing at-a-glance performance assessment, ability to register up to five instruments per programme and cost savings via our unrivalled consolidation.

EQA